SINCE THE INTRODUCTION of succinylcholine to clinical anaesthesia intravenous injection of the drug in 2 per cent solution has been widely practised. Severe bradycardia and arrhythmias are sometimes produced by single or repeated injections and have been described when the drug has been used with most' common anaesthetic agents: thiopentone, nitrous oxide, and oxygen, 1-a trichlorethylene, 3,~ cyclopropane, 8-9 ether, 7'8'6 halothane, 6 n~trous oxide meperidine, 4 nitrous oxide alphaprodine. 8 The incidence of these disturbances n~ust be small, however, because only few cases of cardiovascular collapse under these conditions are recorded, 2'3"~ though doubtless others have occurred. The purpose of this paper is to discuss the circumstances under which succinylcholine bradycardia, and arrhythmia appear during induction of anaesthesia wil~h methoxyflurane.
METHOD
All patients were adolescents or adults suffering froin no cardiac or elc~ctrol? te disturbances. Morphine or meperidine, and atropine or hyoscine, were administered as premedication. After induction of anaesthesia with thiopentone (one patient received none) the patients were artificially ventilated with a mixture containing ,9 L. per minute nitrous oxide and oxygen and approximately 1.3 per cent methoxyflurane into a semi-closed circle absorber system. The patients were arbitrarily divided into three groups, and 2 c.c. 2 per cent succinylcholine given to them according to different sequences: (1) immediately following the thiopentone and four minutes later; (2) four and eight minutes after the thiopentone; (3) eight and twelve minutes after the thiopentone. A fourth group was added in which the succinylcholine was administered according to sequence 2 but in which a second injection of thiopentone, one-third the induction dose, was also made immediately preceding the administration of the repeat dose of succinylcholine. All injections were made rapidly into an antecubital vein. E.C.G. monitoring was done before and for a minute after each injection. The pulse rate was calculated from the maximum R-R interval occurring, and these investigations were completed prior to surgery.
RESULTS
These are presented in Tables I to IV. BraNycardia did not occur when the succinylcholine (SDC) was given immediatelyJafter the induction dose of thiopentone (cf. Table I ). It occurred sometimes when the first dose was given four or eight minutes after the thiopentone (cf. Tables II, Ill, and IV) and was sometimes preceded by a brief and small increase in pulse rgte. Bra,dycardia occasionally *Department of Anaesthesia, University of Alberta ttospltaI Edmonton, Alberta.
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Can. Anaes. Soc. J., vol. 9, no. 5, September, 1962 occurred when the repeat dose was given four minutes after induction (cf. Table I) but was more frequent and severe after the eight and twelve minute repeat doses (cf . Tables II and III) . Arrhythmias consisting, of P wave disturbances and auricular and ventricular conduction defects occurred only after repeat do~es at eight and twelve minutes after induction. Artificial ventilation had no demonstrable effect on these changes.
A second dose of thiopentone given prior to the repeat injection of SDC at eight minutes produced a significant decrease in the incidence of "?radycardia and arrhythmia (cf. Table IV) . Willialns et aI., using succinylcholine with a variety of drugs in man, concluded that the cardiac changes were mediated via s.vmpathetic and parasympathetic efferent nerves. 6 Galindo and Davis explained ,the changes on the basis of s\ mpathetic post-ganglionic stimulation produci@ reflex cardiac effects via the baroreceptors and vagus nerve) ~ thus confirming in monkeys the observations of Beretervide in dogs and rabbits, n The latt6r worked with conscious animals and noted that anaesthesia with pentobarbitone abolished the response. The effectiveness of thiopentone in preventing a response to centrally induced arrhythmias in cats has been demonstrated by Purpura. ~"-The results presented here show the effectiveness of thiopentone in depressing this response to succinylcholine, and it is noteworthy that though this complication has been described with most anaesthetic agents, in a group of six cases anaesthetized with thiopentone intermittently or by continuous drip, severe bradycardia did not ~ccur after either iniection, and arrhythmia occurred in only one instance. 6 Thiopentone injections undergo rapid redistribution within the body and this may account for the inability of the induction dose of thiopentone to provide more than a brief protection. Lupprian and Churchill-Davidson mention further doses of thiopentone given during nitrous oxide-oxygen anaesthesia to satisfy anaesthetic requirements for their investigation 4 but give no other details. Johnstone followed a "small dose" of thiopentone with succinylcholine 60 mg. after a delay of one minute. 2 The fact that both could elicit bradycardia and arrhythmias can be explained by the dosage of thiopentone used and its time of administration relative to that of the succinylcholine.
If thiopentone can reduce the response it might be supposed that the depth o! anaesthesia influences this effect of succinylcholine. 7'6 No attempts have been made to utilize E.E.G. recording for ~ study of this, but in the series presented the depth of anaesthesia at which severe bradycardia occurred was indistinguishable clinically from that at which it failed to occur. A safe correlation between the transient increase in pulse rate and the occurrence of bradycardia subsequently could not be established. The concentration of methoxyflurane used was small, but the difference in the incidence of arrhythmia at the eight and twelve minute periods may indicate a raised threshold due to deeper anaesthesia.
The majority of early reports of this pheuomenon describe its occurrence after a single dose, 2'7'8'9'~ but more recently attention has been drawn to accentuated changes after a repeat dose. These changes may be: irrespecti,~e of the size of the dose 3 or dependent on its; unrelated to the initial dose but related to the repeat dose, which i}mst exceed 25 rag.4; limited to the second and third dose 3 or unlimited to the\number of dosesa; inversely related to the length of time between injections. 6 The complete mechanism of production of succin?lcholine-induced bradycardia and arrhythmia has not been elucidated, but these variable effects may be explained by the ratio of vagomimetic to sympathomimetlc activity of the anaesthetic drugs used, and the thiopentone level in the blood.
Intravenous atropine will reverse an established bradycardia of this origin,"-7 ~ but its use intramuscularly as premedication in this series confirms the very modest protective effe"~t of the drug when used in this manner. G' 4 9 o_ Morton and Thomas have studied the effect of atropine on the pulse rate and stress the importance of administering a substantial dose intravenously to avoid the vagomimetic effects of the drug2 a The intravenous administration of 0.4 rag. atropine during halothane anaesthesia in man has produced evidence of vagal stimulation. ~5 For prophylactic purposes, prior to the succinylcholine, a dosage of at least 0.6-1.0 mg. has been advocated ~ 4 with a delay until a tachycardia has ensued. Atropine considerably increases myocardial sensitivity to carbon dioxide retentio~l during halothane anaesthesia, and under these circumstances ventricular arrhythmias may Occur. 14 In view of the fact that an increase in myocardial excitability due to succinylcholine has been demonstrated in monkeys under halothane anaesthesia and these responses will be influenced by potassium concentrations and other factors, t~ the use of atropine, while providing protection against reflex bradycardia and arrhythmias, may sometimes introduce other hazards to cardiac function during halothane and possibly methoxyflurane anaesthesia.
CONCLUSI ON
The administration of succinylcholine 2 per cent when thiopentone is omitted for induction, or when it is used in minimal doses not immediately preceding the injection of the relaxant, should be done with cautiom The hazard is very small except in patients suffering from cardiac dysfunction Or electrolyte disturbances. A further dose of succinylcholine markedly increases the danger unless prophylactic measures are taken, and a larger dose initially may have a similar effect.
The anaesthesia sequence producing the most marke~l bradycardia and arrhythmias is unusual in clinical practice and when it is used additional thiopentone is often given. These facts probably account for the low incidence of serious complications of this nature. SUMM~Ru
Healthy adolescent or adult patients were premedicated wtth morphine or meperidine, and atropine or hyoscine, and anaesthetized with a sequence thiopentone, nitrous oxide, oxygen, methoxyflurane. They were arbitrarily divided into three groups and intravenous injections of 2 c.c~ 2 per cent succinylcholine given according to three different sequences: (1) immediately following the thiopentone and four minutes later; (2) four and eight minutes after the thiopentone, (3) eight and twelve minutes after the thiopentone. ~ fourth group was added, for which a sequence simila~ to sequence 2 was used except that, prior to the second injection of succinylchotine, a second mjectlon of thiopentone, one-third of the amount used for induction, was given.
The existing reports of succinylcholine-induced bradycardia and arrhythmias are discussed with reference to the results. The conclusions reached are that the I administration of succinylchoIine 2 per cent whe~ thiopentone is omitted for induction, or used in minimal dosage not immediately preceding the injection of the relaxant, should be done with caution. The hazard is very small except in those patients suffering from cardiac dysfunction or electrolyte disturbances. A further dose of succinylcholine markedly increases the danger unless prophylactic measures are taken, and a larger dose initially may have a similar effect.
The anaesthesia sequence producing the most marked bradycardia and arrhythmia is unusual in clinical practice and when it is used additional thiopentone is often given. These facts probably account for the low incidence of serious complications of this nature.
R~:SUM1~
Nous avons pr6m6diqu6 des adolescents ou adultes en sant6 avec de la morphine ou du d6m6rol, et de l'atropine ou de l'hyoscine, et nons les avons anesth6si6s avec du thiopentone du protoxyde d'azote, de I'oxyg&n~l et du m6thoxyflurane. De fagon arbitraire, nous les avons divis6s en trois groupes et des injections intraveineuses de 2 ml. ~t 2 pour cent de succinylcholine leur ont 6t6 donn6es de trois fagons difffirentes: (1) une injection immfidiatement aprils le thmpentone et I'autre quatre minutes plus tard; (2) quatre et huit minutes apr~s le thiopentone; (3) huit et douze minutes apr~s le thiopentone. Nous avons fait un quaVriSme groupe semblable au deuxi~me ~ l'exception que, avant la seconde injection de succinylcholine, une seconde iniection de thiopentone ~tait donn~e repr~sentant le tiers de |a dose donn~e pour l'induction.
Les bradycardies et les arythmies provoqu~es par la succijnylcholine qu'on trouve duns la litt4rature sont discu%es selon les rfisultats mer~tionnfis. Nous en venons aux conclusions qu'il faut agir avec prudence lorsqu'on administre de~la succinylcholine ~ 2 pour cent si l'on omet de donner du thiopentone pour l'induction ou que l'on en in]ecte tr~s peu, ou ~iue l'iniection de thiopentone ne precede pas imm6diatement le myorSsolutif. Le risque est trSs petit, except~ pour les malades porteurs de dysfonction cardiaque ou de dfisfiquilibres filectrolytiques. Une deuxi~me dose de succinylcholine aggrave beaucoup le danger ~. moins que des mesures prophylactiques soient prises, et une plus grosse dose initiale peut produire un effet semblable.
Le m~lange anesth~sique produisant le plus de bradycardie et d'arythmies n'est pan habituel en clinique et, lorsqu'il est employfi, on ajoute du thiopentone. Ces fonts expliquent probablement pourquoi des complications sfirieuses de cette nature ne surviennent pan souvent.
